Goodrx Holdings Inc Cash Flow Conversion Efficiency
Goodrx Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has a cash flow conversion efficiency ratio of 0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.02 Million) by net assets ($600.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Goodrx Holdings Inc (2018–2024)
Cash flow conversion efficiency of Goodrx Holdings Inc from 2018 to 2024. This chart illustrates how Goodrx Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View GDRX share price today for real-time trading data and today's change.
Goodrx Holdings Inc Cash Flow Conversion Ratio Explained
Goodrx Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Goodrx Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Goodrx Holdings Inc ranked by their cash flow conversion efficiency. Also see GDRX market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Consorcio ARA S. A. B. de C. V.
MX:ARA
|
0.017x |
|
Dalian Thermal Power Co Ltd
SHG:600719
|
0.574x |
|
Double Bond Chemical Ind Co Ltd
TW:4764
|
0.040x |
|
Einhell Germany AG
F:EIN
|
0.099x |
|
Tupy S.A
SA:TUPY3
|
0.051x |
|
Spear REIT Ltd
JSE:SEA
|
0.045x |
|
mF International Limited Ordinary Shares
NASDAQ:MFI
|
-0.118x |
|
Van de Velde NV
BR:VAN
|
0.127x |
Annual Cash Flow Conversion Efficiency for Goodrx Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Goodrx Holdings Inc from 2018 to 2024. Review how much free cash does Goodrx Holdings Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $724.66 Million | $183.89 Million | 0.254x | +39.82% |
| 2023-12-31 | $761.96 Million | $138.29 Million | 0.181x | +0.75% |
| 2022-12-31 | $814.83 Million | $146.78 Million | 0.180x | -16.20% |
| 2021-12-31 | $831.68 Million | $178.78 Million | 0.215x | +16.43% |
| 2020-12-31 | $711.36 Million | $131.34 Million | 0.185x | +341.10% |
| 2019-12-31 | $-1.09 Billion | $83.29 Million | -0.077x | -96.71% |
| 2018-12-31 | $-1.16 Billion | $45.25 Million | -0.039x | -- |
About Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more